Prevalence of narcolepsy symptomatology and diagnosis in the European general population
- PMID: 12084885
- DOI: 10.1212/wnl.58.12.1826
Prevalence of narcolepsy symptomatology and diagnosis in the European general population
Abstract
Objective: To determine the prevalence of narcolepsy in the general population of five European countries (target population 205,890,882 inhabitants).
Methods: Overall, 18,980 randomly selected subjects were interviewed (participation rate 80.4%). These subjects were representative of the general population of the UK, Germany, Italy, Portugal, and Spain. They were interviewed by telephone using the Sleep-EVAL expert system, which provided narcolepsy diagnosis according to the International Classification of Sleep Disorders (ICSD).
Results: Excessive daytime sleepiness was reported by 15% of the sample, with a higher prevalence in the UK and Germany. Napping two times or more in the same day was reported by 1.6% of the sample, with a significantly higher rate in Germany. Cataplexy (episodes of loss of muscle function related to a strong emotion), a cardinal symptom of narcolepsy, was found in 1.6% of the sample. An ICSD narcolepsy diagnosis was found in 0.047% of the sample: The narcolepsy was severe for 0.026% of the sample and moderate in 0.021%.
Conclusion: This is the first epidemiologic study that estimates the prevalence of narcolepsy in the general population of these five European countries. The disorder affects 47 individuals/100,000 inhabitants.
Similar articles
-
Prevalence of narcolepsy in representative samples of the general population of North America, Europe, and South Korea.Psychiatry Res. 2025 May;347:116390. doi: 10.1016/j.psychres.2025.116390. Epub 2025 Feb 13. Psychiatry Res. 2025. PMID: 39983282
-
Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.Sleep Med. 2008 May;9(4):425-33. doi: 10.1016/j.sleep.2007.05.006. Epub 2007 Aug 2. Sleep Med. 2008. PMID: 17681883
-
Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders?J Clin Psychiatry. 2009 Jun;70(6):810-6. doi: 10.4088/JCP.08m04272. Epub 2009 May 5. J Clin Psychiatry. 2009. PMID: 19422758
-
Narcolepsy: clinical approach to etiology, diagnosis, and treatment.Rev Neurol Dis. 2011;8(3-4):e97-106. Rev Neurol Dis. 2011. PMID: 22249574 Review.
-
Narcolepsy in the older adult: epidemiology, diagnosis and management.Drugs Aging. 2003;20(5):361-76. doi: 10.2165/00002512-200320050-00005. Drugs Aging. 2003. PMID: 12696996 Review.
Cited by
-
Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005-2013.Health SA. 2018 Jul 31;23:1084. doi: 10.4102/hsag.v23i0.1084. eCollection 2018. Health SA. 2018. PMID: 31934380 Free PMC article.
-
Immunotherapy in Narcolepsy.Curr Treat Options Neurol. 2020 Jan 30;22(1):2. doi: 10.1007/s11940-020-0609-7. Curr Treat Options Neurol. 2020. PMID: 31997035 Review.
-
Migraine and sleep disorders: a systematic review.J Headache Pain. 2020 Oct 27;21(1):126. doi: 10.1186/s10194-020-01192-5. J Headache Pain. 2020. PMID: 33109076 Free PMC article.
-
Narcolepsy Presentation in Diverse Populations: an Update.Curr Sleep Med Rep. 2020;6(4):239-250. doi: 10.1007/s40675-020-00195-7. Epub 2020 Nov 25. Curr Sleep Med Rep. 2020. PMID: 33251089 Free PMC article. Review.
-
Probability estimation of narcolepsy type 1 in DTA mice using unlabeled EEG and EMG data.Sleep Adv. 2025 May 10;6(2):zpaf025. doi: 10.1093/sleepadvances/zpaf025. eCollection 2025 Apr. Sleep Adv. 2025. PMID: 40521226 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources